Medicine and Dentistry
Patient
100%
Therapeutic Procedure
60%
Mycosis fungoides
48%
Nodular Melanoma
31%
Diseases
29%
Diagnosis
21%
Psoriasis
21%
Combination Therapy
20%
Neoplasm
20%
Analysis
20%
Cutaneous T Cell Lymphoma
19%
Inpatient
19%
Syndrome
18%
Melanoma Cell
16%
Consensus
15%
Cells
13%
Dermatology
11%
Cutaneous Lymphoma
11%
Metastatic Melanoma
10%
Skin Carcinoma
10%
B Cell
10%
Phototherapy
10%
Epithelioma
10%
Blood
10%
Skin
9%
Progression Free Survival
8%
Apoplexy
8%
Antibody
8%
MEK Inhibitor
8%
Prevalence
7%
Survival
7%
Quality of Life
7%
Overall Survival
7%
Phenotype
7%
Chemotherapeutic Agent
6%
Drug
6%
Plaque
6%
Chlormethine
6%
Tissues
6%
Life
6%
Monoclonal Antibody
6%
Nivolumab
5%
Kidney Transplantation
5%
Dabrafenib
5%
Trametinib
5%
Proteochondroitin Sulfate
5%
Comprehension
5%
Adverse Event
5%
Evolution
5%
Hypoxia Inducible Factor 1
5%
Aminolevulinic Acid
5%
Heat Shock Protein 27
5%
Therapy Resistance
5%
Pathogen
5%
Nonsense Mutation
5%
Sneddon Syndrome
5%
Lymphocyte
5%
Pediatric Stroke
5%
Apremilast
5%
Tumour Heterogeneity
5%
Predictor
5%
Sorafenib
5%
DNA Repair
5%
Cancer Treatment
5%
Patient Referral
5%
Vasculotropin
5%
Fibrinogen
5%
Melanocytosis
5%
Cushing Disease
5%
Carney Complex
5%
Mast Cell
5%
Perception
5%
Hematologic Malignancy
5%
Talimogene Laherparepvec
5%
Chondroitin Sulfate
5%
Notch
5%
Cancer Therapy
5%
Leg Ulcer
5%
T-Cell Lymphoma
5%
RNA Sequence
5%
Lymphoma
5%
Instability
5%
Notch Signaling
5%
Hepatocellular Carcinoma
5%
Uvomorulin
5%
Motivation
5%
Clusterin
5%
Skin Cancer
5%
Hemosiderin
5%
Tumor Spheroid
5%
Pigmentation
5%
Case Report
5%
Cell Invasion
5%
Neutrophil
5%
Outpatient
5%
Platelet
5%
Cross Sectional Study
5%
Actinic Keratosis
5%
Diabetic Foot
5%
Diabetic Foot Ulcer
5%
Pharmacology, Toxicology and Pharmaceutical Science
Melanoma
18%
Psoriasis
17%
Drug
16%
Antibody
15%
Allergen
14%
Survival
13%
Biological Product
11%
Neoplasm
10%
Immunoglobulin E
10%
Peanut
10%
Mycosis fungoides
10%
Survival Rate
7%
Nivolumab
7%
Adverse Event
7%
Rat
7%
Diseases
6%
Monoclonal Antibody
6%
Etanercept
6%
Adalimumab
6%
Mitogen Activated Protein Kinase Kinase Inhibitor
6%
Cutaneous T Cell Lymphoma
6%
Metastatic Melanoma
5%
Psoriasis Vulgaris
5%
Recurrent Disease
5%
Dabrafenib
5%
Sorafenib
5%
Apremilast
5%
Interleukin 17 Antibody
5%
Therapy Resistance
5%
Skin Cancer
5%
Tumor Necrosis Factor Inhibitor
5%
Skin Carcinoma
5%
Talimogene Laherparepvec
5%
Defined Daily Dose
5%
Epithelium Tumor
5%
Programmed Death 1 Receptor
5%
Interleukin 23 Antibody
5%
Peptide
5%
Aminolevulinic Acid
5%
Hemosiderin
5%
Juglans
5%
DNA
5%
Proteochondroitin Sulfate
5%
Hematologic Malignancy
5%
Liver Cell Carcinoma
5%
Fibrinogen
5%
Deuterium Oxide
5%
Lactobacillus buchneri
5%
Aneuploidy
5%
Nitrogen Mustard
5%
Infectious Agent
5%
Tree
5%
Lipid
5%
Cytokine
5%
Immunotherapy
5%
Vicilin
5%
Cell Proliferation
5%
Fish
5%
foot ulcer, diabetic
5%
Immunology and Microbiology
Allergen
53%
Immunoglobulin E
52%
Allergy
35%
Fish
26%
Epitope
12%
Species
11%
Allergenicity
10%
Neutrophil Granulocyte
10%
ELISA
9%
Extract
9%
Sensitization
8%
Basophil Granulocyte
8%
Cells
8%
Escherichia coli
7%
Development
7%
Molecular Weight
7%
Monospecific Antibody
6%
Birch
6%
Protein Binding
5%
Immunotherapy
5%
Pollen
5%
Molecule
5%
Cartilaginous Fish
5%
Programmed Death-Ligand 1
5%
Platelet
5%
Data Base
5%
Mastocytosis
5%
Lactobacillus buchneri
5%
Single-Chain Variable Fragment
5%
Mast Cell
5%
Permeability Barrier
5%
Heat Shock
5%
Proinflammatory Cytokine
5%
Nomenclature
5%
Fibrinogen
5%
Nicotiana benthamiana
5%
Antigen Presentation
5%
Skin
5%